Amphastar Pharmaceuticals Inc (AMPH)
41.00
+0.09
(+0.22%)
USD |
NASDAQ |
Apr 24, 16:00
40.98
-0.02
(-0.04%)
After-Hours: 20:00
Amphastar Pharmaceuticals Profit Margin (Quarterly): 20.31% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.31% |
| September 30, 2023 | 27.26% |
| June 30, 2023 | 17.93% |
| March 31, 2023 | 18.59% |
| December 31, 2022 | 25.12% |
| September 30, 2022 | 13.21% |
| June 30, 2022 | 14.05% |
| March 31, 2022 | 20.15% |
| December 31, 2021 | 16.35% |
| September 30, 2021 | 26.34% |
| June 30, 2021 | 7.64% |
| March 31, 2021 | 4.89% |
| December 31, 2020 | -6.54% |
| September 30, 2020 | 4.70% |
| June 30, 2020 | -0.22% |
| March 31, 2020 | 4.66% |
| December 31, 2019 | -1.23% |
| September 30, 2019 | 1.63% |
| June 30, 2019 | 60.45% |
| March 31, 2019 | 1.09% |
| December 31, 2018 | 2.08% |
| September 30, 2018 | 3.16% |
| Date | Value |
|---|---|
| June 30, 2018 | -4.02% |
| March 31, 2018 | -12.23% |
| December 31, 2017 | 1.30% |
| September 30, 2017 | 0.17% |
| June 30, 2017 | 3.03% |
| March 31, 2017 | 1.58% |
| December 31, 2016 | -5.44% |
| September 30, 2016 | 6.06% |
| June 30, 2016 | 10.13% |
| March 31, 2016 | 4.19% |
| December 31, 2015 | 9.79% |
| September 30, 2015 | -4.71% |
| June 30, 2015 | -12.34% |
| March 31, 2015 | -1.17% |
| December 31, 2014 | -4.51% |
| September 30, 2014 | -9.01% |
| June 30, 2014 | -2.41% |
| March 31, 2014 | -3.53% |
| December 31, 2013 | 3.33% |
| September 30, 2013 | -0.27% |
| June 30, 2013 | 12.49% |
| March 31, 2013 | 4.50% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.54%
Minimum
Dec 2020
60.45%
Maximum
Jun 2019
14.49%
Average
14.05%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 23.41% |
| Dentsply Sirona Inc | 6.62% |
| Pacira BioSciences Inc | 13.72% |
| Organon & Co | 34.17% |
| NovaBay Pharmaceuticals Inc | -110.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.71% |
| Return on Assets | 11.56% |
| Return on Invested Capital | 14.38% |
| Gross Profit Margin (Quarterly) | 53.98% |
| Operating Margin (Quarterly) | 30.31% |
| Return on Net Operating Assets | 15.41% |